Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Buy
4,912
+412
+9% +$38.8K 0.03% 300
2026
Q1
$532K Buy
4,500
+1,668
+59% +$206K 0.05% 234
2025
Q4
$356K Sell
2,832
-91
-3% -$11.9K 0.03% 321
2025
Q3
$428K Buy
2,923
+1,449
+98% +$219K 0.03% 267
2025
Q2
$230K Sell
1,474
-124
-8% -$19.7K 0.02% 354
2025
Q1
$263K Sell
1,598
-686
-30% -$114K 0.02% 375
2024
Q4
$372K Sell
2,284
-365
-14% -$65.3K 0.03% 365
2024
Q3
$518K Buy
2,649
+69
+3% +$12.7K 0.04% 272
2024
Q2
$447K Sell
2,580
-433
-14% -$72.1K 0.04% 282
2024
Q1
$510K Buy
3,013
+565
+23% +$106K 0.04% 283
2023
Q4
$483K Buy
+2,448
New +$433K 0.04% 281

Other funds holding ZTS

Trust Point Inc's ZTS Position: Q2 2026 in Review

Trust Point Inc increased its Zoetis (ZTS) stake by 9.2% in Q2 2026, buying an estimated $38.8K and bringing the position to 4,912 shares worth $353K. The position accounts for 0.03% of the portfolio, ranked #300.

Trust Point Inc first reported a position in ZTS in Q4 2023 and has held it in 11 quarters since. The position peaked at $532K in Q1 2026. 234 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Trust Point Inc held 4,912 shares of Zoetis worth $353K as of Q2 2026.
  • Trust Point Inc bought 412 Zoetis shares in Q2 2026, an estimated $38.8K.
  • Zoetis made up 0.03% of Trust Point Inc's portfolio in Q2 2026, its #300 holding.
  • Trust Point Inc first reported a position in Zoetis in Q4 2023 and has held it in 11 quarters since.
  • Trust Point Inc's Zoetis position peaked at $532K in Q1 2026.
  • 234 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.